Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

MUM1 Inhibitors

MUM1 inhibitors represent a specific class of chemical compounds designed to interfere with the activity of the MUM1 (Multiple Myeloma 1) protein, which is a transcription factor involved in various biological processes, including the regulation of gene expression. As a member of the interferon regulatory factor (IRF) family, MUM1 plays a crucial role in modulating immune response, cellular differentiation, and proliferation. The inhibition of MUM1 can have far-reaching consequences in molecular biology, especially in the study of transcriptional regulation mechanisms. By selectively targeting MUM1, researchers can dissect its involvement in specific signaling pathways and its downstream effects on the expression of certain genes. These inhibitors are valuable tools in cellular biology, enabling the exploration of MUM1's influence on chromatin remodeling and epigenetic modifications.

From a chemical perspective, MUM1 inhibitors are often small molecules engineered to achieve high specificity for the MUM1 protein. Their design typically revolves around a core structure capable of binding to the MUM1 transcription factor, thus preventing its interaction with DNA or other co-factors that facilitate transcriptional activity. These inhibitors may feature diverse functional groups and moieties that confer the necessary affinity and selectivity for MUM1 binding. In the development and refinement of these compounds, various chemical techniques, including structure-activity relationship (SAR) studies, are employed to optimize potency and selectivity. MUM1 inhibitors are synthesized and analyzed using advanced spectroscopic, crystallographic, and chromatographic techniques, allowing researchers to precisely characterize their molecular interactions and binding properties. This class of inhibitors, by providing insight into the fundamental molecular interactions within transcriptional networks, has emerged as a key focus in the study of gene regulation and molecular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

May modulate the activity of immune cells, indirectly affecting MUM1 expression in hematological malignancies.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Could affect cytokine production and immune responses, indirectly modulating MUM1 expression.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

BTK inhibitor that may impact B-cell receptor signaling, potentially influencing MUM1 expression.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

JAK inhibitor; may modulate cytokine signaling pathways affecting MUM1 expression.

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

PI3Kδ inhibitor; could influence B-cell activation and survival, possibly affecting MUM1 expression.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor; may indirectly influence MUM1 expression through apoptosis regulation in malignancies.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Tyrosine kinase inhibitor that might affect various signaling pathways influencing MUM1 expression.

Acalabrutinib

1420477-60-6sc-507392
250 mg
$255.00
(0)

BTK inhibitor; may impact B-cell receptor signaling, potentially affecting MUM1 expression.

IPI 145

1201438-56-3sc-488318
5 mg
$317.00
(0)

PI3K inhibitor; could modulate cell survival and activation pathways, influencing MUM1 expression.

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$200.00
$664.00
(1)

JAK inhibitor; could influence cytokine-mediated signaling pathways, affecting MUM1 expression.